Home > Analytics > INNOVA CAPTAB

INNOVA CAPTAB
Intrinsic Value | Fundamental Analysis

BOM : 544067     NSE : INNOVACAP    
LT :  
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive]
Debt : High
Updated:
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Neutral
Price Momentum : Upward
Pledged Shares : None or < 25%
Mar 28,2025
Price(EOD): ₹ 877.50
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
Pharmaceuticals & Drugs
MCap: ₹ 5,019.30 Cr
Value of ₹ 1 Lac invested in INNOVA CAPTAB
on Dec 29,2023 (price: ₹ 545.15)

₹ 1 L

₹ 1.61 L

1W : -6.6% 1M : 13.2% 1Y : 88.9%
COMMUNITY POLL
for INNOVA CAPTAB
Please provide your vote to see the results
INNOVA CAPTAB is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best 1M Momentum Small Cap Stocks
Industry Peers & Returns1W1M1Y
INNOVA CAPTAB -6.6% 13.2% 88.9%
SUN PHARMACEUTICAL INDUSTRIES -2.8% 7.6% 8.4%
DIVIS LABORATORIES -2.3% 0.8% 72.7%
CIPLA -5.4% -1.5% 0.8%
TORRENT PHARMACEUTICALS -0.8% 6.8% 25.6%
DR REDDYS LABORATORIES -5.5% 1.6% -5.1%
MANKIND PHARMA 2.1% 3.7% 9.5%
ZYDUS LIFESCIENCES -4.4% 0.4% -12.5%
LUPIN -4.5% 6.9% 25.2%

FUNDAMENTAL ANALYSIS OF INNOVA CAPTAB

 
Fundamentals Score
[ Q(TTM): Dec2024, Y: Mar2024
Q : Last Qtr data
Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
]

Insights 💡 INNOVACAP is one of the top 37% companies with good fundamentals ! Discover More →

VALUATION OF INNOVA CAPTAB

 
Valuation Score
[As on : Mar 28,2025 ]

Ratio Consolidated
P/E
P/B
P/S
39.41
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs 127.41 Cr
[Latest Qtr - Dec2024 - Consolidated Results ]

6.04
P/B Calculated based on Book Value of Rs 830.89 Cr
[Latest Year - Mar2024 - Consolidated Results ]

4.21
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 1,191.57 Cr
[Latest Qtr - Dec2024 - Consolidated Results ]

Financial Ratios →

Insights 💡 There are potential 23% undervalued companies ! Discover More →

FAIR VALUE OF INNOVA CAPTAB

 
Model Discount(-)/
Premium(+)
EV/EBIDTA
EV/Sales
Price/Sales
2651%
3161%
58%

Insights 💡 You can learn about various Valuation techniques to calculate Intrinsic Value
with our bestselling video course Value Investing - The Ultimate Guide
Take Me There →

SHARE PRICE MOMENTUM OF INNOVA CAPTAB


Insights 💡 INNOVACAP is one of the top 21% companies with bullish price momentum currently! Discover More →

INNOVA CAPTAB vs SENSEX


Insights 💡 You can learn about Basics of Stock Marketing Investing
with our bestselling video course Stock Marketing Investing Simplified
Take Me There →

DEBT OF INNOVA CAPTAB

Year Debt/Equity ratio
Standalone Consolidated
2024
2023
2022
Avg_3yrs
0.33
0.88
0.84
0.68
0.29
0.85
0.95
0.7
[Last Annual Data : Mar2024]
Financial Ratios →

PLEDGED PROMOTER SHARES OF INNOVA CAPTAB

Pledged Promoter Shares
0 %
As on : Dec2024

If less than 25%

Good
If between 25% and 50% Neutral
If greater than 50% Bad
Shareholding Pattern →

QTRLY RESULTS OF INNOVA CAPTAB

Consolidated Q-o-Q Y-o-Y
Revenue
Op Profit
Profit Before Tax
Profit After Tax
-0.55%
-6.38%
-2.61%
-2.29%
4.62%
4.4%
29.51%
36.13%
QtrlyTrend
0
Latest Qtr: Dec2024
Quarterly Result Analysis →


INNOVA CAPTAB related INDICES

BSE Indices1W1M1Y
BSE ALLCAP 1.5% 3.4% 7.5%
BSE MIDSMALLCAP -1.1% 3.4% 8.1%
BSE SMALLCAP -1.4% 3.1% 9%
BSE HEALTHCARE -1.7% 5% 20.1%
NSE Indices1W1M1Y
NIFTY TOTAL MARKET 0.2% 4.1% 6.8%
NIFTY IPO INDEX -0.7% 0.1% NA
NIFTY MICROCAP 250 -3.2% 0.9% 9.2%

You may also like the below Video Courses


FAQ about INNOVA CAPTAB


Is INNOVA CAPTAB good for long term investment?

As on Mar 28,2025, the Fundamentals of INNOVA CAPTAB look Strong and hence it may be good for long term investment! See Financial Performance of INNOVA CAPTAB . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!

Is INNOVA CAPTAB UnderValued or OverValued?

As on Mar 28,2025, INNOVA CAPTAB is Over Valued based on the estimates of intrinsic value and hence may not be a good buying opportunity according to Share Valuation at this time!

What is the Intrinsic Value of INNOVA CAPTAB ?

As on Mar 28,2025, the Intrinsic Value of INNOVA CAPTAB is Rs. 31.90 estimated based on Median of the 3 historical models.
Fair Value [Median EV / EBIDTA Model] : Rs. 31.90
Fair Value [Median EV / Sales Model] : Rs. 26.91
Fair Value [Median Price / Sales Model] : Rs. 555.19
Estimated Median Fair Value of INNOVA CAPTAB : Rs. 31.90

The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.

Is INNOVA CAPTAB trading at a Premium or Discount?

As on Mar 28,2025, INNOVA CAPTAB is trading at a Premium of 2651% based on the estimates of Median Intrinsic Value!